69.1 F
Fort Worth
Thursday, October 22, 2020
Technology Alcon set to trade on NYSE, Swiss exchange on April 9

Alcon set to trade on NYSE, Swiss exchange on April 9

Other News

A look at big issues on Supreme Court’s agenda

Some of the issues either already on the Supreme Court's docket when it begins its new session or likely to be before...

Wall Street posts solid gains after surge in corporate deals

By ALEX VEIGA and DAMIAN J. TROISE AP Business Writers Wall Street kicked off the week with a broad...

Tarrant County ranks low in work-from-home study by NAR

North Texas ranks pretty high in the “Work from Home” category, according to a just-released study by the National Association of Realtors....

Commentary: Universities and COVID-19: Charting turbulent times

Ray Perryman As the COVID-19 pandemic emerged this spring, college campuses across the United States swiftly sent students...

Fort Worth-based Alcon, the eye-care business of Novartis, is expected to start trading on the New York Stock Exchange and the Swiss market on April 9, the Zurich, Switzerland-based parent company announced March 22.

Approval has been given, subject to customary conditions, by the SIX Exchange Regulation for the listing of the shares of Alcon Inc. on the SIX Swiss Exchange (SIX) pursuant to the International Reporting Standard. Authorization has also been received for the listing of shares in Alcon Inc. on the New York Stock Exchange (NYSE).

Alcon has secured debt financing of USD 3.5 billion through a group of banks. The Alcon credit rating will be investment grade following the spin-off. Moody’s Investor Service and S&P Global Ratings have rated Alcon at Baa2 and BBB, respectively, with a stable outlook.

Bank of America Merrill Lynch and UBS AG are advising Novartis on the transaction.

Alcon announced March 18 it has acquired PowerVision Inc., a privately-held, U.S.-based medical device development company focused on creating fluid-based intraocular lens implants.

Novartis said last year it would sell the eye care business to focus less on the surgical devices and contact lenses from Alcon.

Latest News

How Google evolved from ‘cuddly’ startup to antitrust target

By MICHAEL LIEDTKE AP Technology Writer SAN RAMON, Calif. (AP) — In Google's infancy, co-founders Larry Page and Sergey...

Twitter CEO says it was wrong to block links to Biden story

By KELVIN CHAN Associated Press Twitter was wrong to block weblinks to an unverified political story, CEO Jack Dorsey...

Linear Labs raises $6 million in new funding

Smarter energy company Linear Labs has raised an additional $6 million in funding to further develop manufacturing capabilities and grow its employee...

Five things to know about the Big Tech antitrust report

By The Associated Press After years of calling Big Tech too big, Democratic lawmakers are calling for Congress to rein in Facebook,...

Fort Worth among cities in Facebook voting project

Today is the last day to register to vote in Texas. On the same...